[IMRX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[IMRX] Immuneering Corporation
Announcement Date
01-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -19.75%
YoY- -20.61%
Quarter Report
IMRX's Result
IMRX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
Revenue -94,419 0 190 665 -
PBT -15,084 -13,246 -11,092 -5,836 37.23%
Tax -755 -740 -307 42 -
NP -15,083 -12,506 -10,784 -5,836 37.23%
Tax Rate - - - - -
Total Cost -79,336 12,506 10,974 6,501 -
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
NP Margin 15.98 -2,742,434.65 -5,688.22 -877.48 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 CAGR
EPS -0.52 -0.47 -0.42 -0.43 6.53%
EPS Diluted -0.52 -0.47 -0.42 -0.43 6.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.